All Stories

  1. Developmental Trajectories of Adaptive Functioning and Behavior Problems in Children With Co-Occurring Tuberous Sclerosis Complex and Autism Spectrum Disorder, With and Without Seizures
  2. Neurodevelopmental Outcomes from the PREVeNT Trial
  3. Electroencephalogram (EEG) Spike Metrics Discriminate Impending Epileptic Spasms From Other Seizures in Children With Tuberous Sclerosis Complex: A Pilot Study
  4. Arrayed CRISPR/Cas9 Loss-Of-Function Screen in a Neuronal Model of Adaptor Protein Complex 4 Deficiency Identifies Modulators of ATG9A Trafficking
  5. Construction destruction: Contribution of dyregulated proteostasis to neurodevelopmental disorders
  6. Human TSC2 mutant cells exhibit aberrations in early neurodevelopment accompanied by changes in the DNA Methylome
  7. A Hybrid 2D‐to‐3D in vitro Differentiation Platform Improves Outcomes of Cerebral Cortical Organoid Generation in hiPSCs
  8. Drug Resistant Epilepsy in Tuberous Sclerosis Complex is Associated with TSC2 Genotype: More Findings from the PREVeNT Trial
  9. AAV gene therapy for hereditary spastic paraplegia type 50: a phase 1 trial in a single patient
  10. Human TSC2 Mutant Cells Exhibit Aberrations in Early Neurodevelopment Accompanied by Changes in the DNA Methylome
  11. Gene replacement therapies for inherited disorders of neurotransmission: Current progress in succinic semialdehyde dehydrogenase deficiency
  12. The role of TSC1 and TSC2 proteins in neuronal axons
  13. A roadmap for SHANK3-related Epilepsy Research: recommendations from the 2023 strategic planning workshop
  14. Rescue of Impaired Blood-Brain Barrier in Tuberous Sclerosis Complex Patient Derived Neurovascular Unit
  15. Non-canonical functions of a mutant TSC2 protein in mitotic division
  16. Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT Trial
  17. Increased degradation of FMRP contributes to neuronal hyperexcitability in tuberous sclerosis complex
  18. Intrathecal AAV9/AP4M1 gene therapy for hereditary spastic paraplegia 50 shows safety and efficacy in preclinical studies
  19. Large 22q13.3 deletions perturb peripheral transcriptomic and metabolomic profiles in Phelan-McDermid syndrome
  20. Non-Canonical Functions of a Mutant TSC2 Protein in Mitotic Division
  21. GENE TARGET: A framework for evaluating Mendelian neurodevelopmental disorders for gene therapy
  22. Tubers affecting the fusiform face area are associated with autism diagnosis
  23. The clinical and molecular spectrum of ZFYVE26-associated hereditary spastic paraplegia: SPG15
  24. Direct-to-Consumer Recruitment Methods for Clinical Trials for Rare Diseases: A Novel Approach for Testing the Application of Targeted Social Media Messaging to Aid in Accrual Into Research Studies (Preprint)
  25. Direct-to-Consumer Recruitment Methods for Clinical Trials for Rare Diseases: A Novel Approach for Testing the Application of Targeted Social Media Messaging to Aid in Accrual Into Research Studies (Preprint)
  26. Novel CAPN1 missense variants in complex hereditary spastic paraplegia with early‐onset psychosis
  27. AP-4-mediated axonal transport controls endocannabinoid production in neurons
  28. Single-cell dissection of the human brain vasculature
  29. Convergent Cerebrospinal Fluid Proteomes and Metabolic Ontologies in Humans and Animal Models of Rett Syndrome
  30. Endothelial GNAQ p.R183Q Increases ANGPT2 (Angiopoietin-2) and Drives Formation of Enlarged Blood Vessels
  31. Enhanced prime editing systems by manipulating cellular determinants of editing outcomes
  32. Epilepsy Is Heterogeneous in Early-Life Tuberous Sclerosis Complex
  33. Phenotypic characterization of Cdkl5-knockdown neurons establishes elongated cilia as a functional assay for CDKL5 Deficiency Disorder
  34. Loss of Tsc1 in cerebellar Purkinje cells induces transcriptional and translation changes in FMRP target transcripts
  35. Factors influencing the acute pentylenetetrazole‐induced seizure paradigm and a literature review
  36. Balancing serendipity and reproducibility: Pluripotent stem cells as experimental systems for intellectual and developmental disorders
  37. 16p11.2 deletion is associated with hyperactivation of human iPSC-derived dopaminergic neuron networks and is rescued by RHOA inhibition in vitro
  38. Generation and characterization of human induced pluripotent stem cells (iPSCs) from three male and three female patients with CDKL5 Deficiency Disorder (CDD)
  39. Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4M1-associated hereditary spastic paraplegia (SPG50)
  40. Shifted phase of EEG cross-frequency coupling in individuals with Phelan-McDermid syndrome
  41. Single-cell dissection of the human cerebrovasculature in health and disease
  42. Loss of Tsc1 in cerebellar Purkinje cells induces transcriptional and translation changes in FMRP target transcripts
  43. A randomized double-blind controlled trial of everolimus in individuals with PTEN mutations: Study design and statistical considerations
  44. Brief Report: Role of Parent-Reported Executive Functioning and Anxiety in Insistence on Sameness in Individuals with Germline PTEN Mutations
  45. Early Pandemic Experiences of Autistic Adults: Predictors of Psychological Distress
  46. Cross-level analysis of molecular and neurobehavioral function in a prospective series of patients with germline heterozygous PTEN mutations with and without autism
  47. Tuber Locations Associated with Infantile Spasms Map to a Common Brain Network
  48. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
  49. Brief Report: Impact of COVID-19 on Individuals with ASD and Their Caregivers: A Perspective from the SPARK Cohort
  50. Correction: Low-level mosaicism in tuberous sclerosis complex: prevalence, clinical features, and risk of disease transmission
  51. A Cell-Based Assay Optimized for High-Content Cilia Imaging with Primary Rat Hippocampal Neurons
  52. Epilepsy Risk Prediction Model for Patients With Tuberous Sclerosis Complex
  53. Editorial: Biomarkers to Enable Therapeutics Development in Neurodevelopmental Disorders
  54. Tuberous sclerosis: a review of the past, present, and future
  55. The Impact of COVID-19 on Individuals With Intellectual and Developmental Disabilities: Clinical and Scientific Priorities
  56. Author Correction: Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders
  57. Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile
  58. Polymicrogyria is Associated With Pathogenic Variants in PTEN
  59. Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders
  60. Defining the clinical, molecular and imaging spectrum of adaptor protein complex 4-associated hereditary spastic paraplegia
  61. Pilot Study of Neurodevelopmental Impact of Early Epilepsy Surgery in Tuberous Sclerosis Complex
  62. Correction: Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders
  63. Phenotypic Screen with TSC-Deficient Neurons Reveals Heat-Shock Machinery as a Druggable Pathway for mTORC1 and Reduced Cilia
  64. Psychometric Study of the Social Responsiveness Scale in Phelan–McDermid Syndrome
  65. Author Correction: Neuronal activity regulates DROSHA via autophagy in spinal muscular atrophy
  66. Diffusion Tensor Imaging Abnormalities in the Uncinate Fasciculus and Inferior Longitudinal Fasciculus in Phelan-McDermid Syndrome
  67. Epilepsy and Neurodevelopmental Comorbidities in Tuberous Sclerosis Complex: A Natural History Study
  68. Tau: A Novel Entry Point for mTOR-Based Treatments in Autism Spectrum Disorder?
  69. Deep learning in rare disease. Detection of tubers in tuberous sclerosis complex
  70. Auditory Processing of Speech and Tones in Children With Tuberous Sclerosis Complex
  71. Learning to Detect Brain Lesions from Noisy Annotations
  72. Posterior Neocortex-Specific Regulation of Neuronal Migration by CEP85L Identifies Maternal Centriole-Dependent Activation of CDK5
  73. Loss of ap4s1 in zebrafish leads to neurodevelopmental defects resembling spastic paraplegia 52
  74. A novel approach to conducting clinical trials in the community setting: utilizing patient-driven platforms and social media to drive web-based patient recruitment
  75. Psychiatric and Medical Profiles of Autistic Adults in the SPARK Cohort
  76. Recent advances in human stem cell-based modeling of Tuberous Sclerosis Complex
  77. Beliefs in vaccine as causes of autism among SPARK cohort caregivers
  78. Language predictors of autism spectrum disorder in young children with tuberous sclerosis complex
  79. Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking
  80. Lesion-Constrained Electrical Source Imaging
  81. Modeling Neurodevelopmental Deficits in Tuberous Sclerosis Complex with Stem Cell Derived Neural Precursors and Neurons
  82. The Connectivity Fingerprint of the Fusiform Gyrus Captures the Risk of Developing Autism in Infants with Tuberous Sclerosis Complex
  83. EEG Spectral Features in Sleep of Autism Spectrum Disorders in Children with Tuberous Sclerosis Complex
  84. Early white matter development is abnormal in tuberous sclerosis complex patients who develop autism spectrum disorder
  85. Scalp EEG spikes predict impending epilepsy in TSC infants: A longitudinal observational study
  86. Neurobehavioral phenotype of autism spectrum disorder associated with germline heterozygous mutations in PTEN
  87. Biallelic mutations in TSC2 lead to abnormalities associated with cortical tubers in human iPSC-derived neurons
  88. Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4B1-associated hereditary spastic paraplegia (SPG47)
  89. A framework for the investigation of rare genetic disorders in neuropsychiatry
  90. Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes
  91. Early patterns of functional brain development associated with autism spectrum disorder in tuberous sclerosis complex
  92. Reproducibility of Structural and Diffusion Tensor Imaging in the TACERN Multi-Center Study
  93. Resting‐State fMRI Networks in Children with Tuberous Sclerosis Complex
  94. Increased electroencephalography connectivity precedes epileptic spasm onset in infants with tuberous sclerosis complex
  95. The Evolution of Subclinical Seizures in Children With Tuberous Sclerosis Complex
  96. White matter mean diffusivity correlates with myelination in tuberous sclerosis complex
  97. Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders
  98. Chronic mTORC1 inhibition rescues behavioral and biochemical deficits resulting from neuronal Depdc5 loss in mice
  99. Low-level mosaicism in tuberous sclerosis complex: prevalence, clinical features, and risk of disease transmission
  100. Genetic Etiologies, Diagnosis, and Treatment of Tuberous Sclerosis Complex
  101. Impacting development in infants with tuberous sclerosis complex: Multidisciplinary research collaboration.
  102. Tuberous Sclerosis Complex Genotypes and Developmental Phenotype
  103. Probing Mechanical Properties of Brain in a Tuberous Sclerosis Model of Autism
  104. Translational Medicine Strategies in Drug Development for Neurodevelopmental Disorders
  105. Volumetric Analysis of the Basal Ganglia and Cerebellar Structures in Patients with Phelan-McDermid Syndrome
  106. Discovering translational biomarkers in neurodevelopmental disorders
  107. Electrographic spikes are common in wildtype mice
  108. High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex
  109. Motion-robust diffusion compartment imaging using simultaneous multi-slice acquisition
  110. Yield of Emergent Neuroimaging in Patients With Sturge-Weber Syndrome Presenting With Acute Neurologic Symptoms
  111. Data-driven analyses revealed the comorbidity landscape of tuberous sclerosis complex
  112. Longitudinal effects of everolimus on white matter diffusion in Tuberous Sclerosis Complex
  113. Sensitive Periods for Cerebellar-Mediated Autistic-like Behaviors
  114. The mouse as a model for neuropsychiatric drug development
  115. The Way Forward for Mechanism-Based Therapeutics in Genetically Defined Neurodevelopmental Disorders
  116. A Unified Circuit for Social Behavior
  117. Abnormal mTOR Activation in Autism
  118. Author Correction: Neuronal activity regulates DROSHA via autophagy in spinal muscular atrophy
  119. Recurrence quantification analysis of resting state EEG signals in autism spectrum disorder – a systematic methodological exploration of technical and demographic confounders in the search for biomarkers
  120. Automated Detection of High Frequency Oscillations in Human Scalp Electroencephalogram
  121. Quantitative Apparent Diffusion Coefficient Mapping May Predict Seizure Onset in Children With Sturge-Weber Syndrome
  122. Visual and semi-automatic non-invasive detection of interictal fast ripples: A potential biomarker of epilepsy in children with tuberous sclerosis complex
  123. mTOR’ing across the Cortex by Chopping the Cilia
  124. Neuronal activity regulates DROSHA via autophagy in spinal muscular atrophy
  125. Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex
  126. Cerebellar volume as an imaging marker of development in infants with tuberous sclerosis complex
  127. A mouse model of DEPDC5 -related epilepsy: Neuronal loss of Depdc5 causes dysplastic and ectopic neurons, increased mTOR signaling, and seizure susceptibility
  128. Purkinje cells derived from TSC patients display hypoexcitability and synaptic deficits associated with reduced FMRP levels and reversed by rapamycin
  129. SPARK: A US Cohort of 50,000 Families to Accelerate Autism Research
  130. Placebo-controlled crossover assessment of mecasermin for the treatment of Rett syndrome
  131. mGluR5 Modulation of Behavioral and Epileptic Phenotypes in a Mouse Model of Tuberous Sclerosis Complex
  132. Clinical and genetic characterization of AP4B1 -associated SPG47
  133. Corpus Callosum White Matter Diffusivity Reflects Cumulative Neurological Comorbidity in Tuberous Sclerosis Complex
  134. Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders
  135. Presentation and Diagnosis of Tuberous Sclerosis Complex in Infants
  136. Utility of the Autism Observation Scale for Infants in Early Identification of Autism in Tuberous Sclerosis Complex
  137. Early autism symptoms in infants with tuberous sclerosis complex
  138. Aberrant Proteostasis of BMAL1 Underlies Circadian Abnormalities in a Paradigmatic mTOR-opathy
  139. Classification of respiratory disturbances in Rett Syndrome patients using Restricted Boltzmann Machine
  140. Autism spectrum disorder and epileptic encephalopathy: common causes, many questions
  141. Replicable in vivo physiological and behavioral phenotypes of the Shank3B null mutant mouse model of autism
  142. Defining Hand Stereotypies in Rett Syndrome: A Movement Disorders Perspective
  143. Increased Survival and Partly Preserved Cognition in a Patient With ACO2-Related Disease Secondary to a Novel Variant
  144. p62/SQSTM1 Cooperates with Hyperactive mTORC1 to Regulate Glutathione Production, Maintain Mitochondrial Integrity, and Promote Tumorigenesis
  145. Influence of seizures on early development in tuberous sclerosis complex
  146. Combination Clearance Therapy and Barbiturate Coma for Severe Carbamazepine Overdose
  147. Translational use of event-related potentials to assess circuit integrity in ASD
  148. Neuronal CTGF/CCN2 negatively regulates myelination in a mouse model of tuberous sclerosis complex
  149. Using tuberous sclerosis complex to understand the impact of MTORC1 signaling on mitochondrial dynamics and mitophagy in neurons
  150. Impaired Mitochondrial Dynamics And Mitophagy In Neuronal Models Of Tuberous Sclerosis Complex
  151. Somatic GNAQ mutation is enriched in brain endothelial cells in Sturge-Weber Syndrome
  152. Impaired Mitochondrial Dynamics and Mitophagy in Neuronal Models of Tuberous Sclerosis Complex
  153. The Pediatric Neurology Trainee Publication Award for 2015
  154. Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A
  155. Characterizing Multiscale Mechanical Properties of Brain Tissue Using Atomic Force Microscopy, Impact Indentation, and Rheometry
  156. Symptom profiles of autism spectrum disorder in tuberous sclerosis complex
  157. Effect of Angiofibromas on Quality of Life and Access to Care in Tuberous Sclerosis Patients and Their Caregivers
  158. Direct current stimulation induces mGluR5-dependent neocortical plasticity
  159. White and gray matter fiber pathways in autism spectrum disorder revealed by ex vivo diffusion MR tractography
  160. Leveraging a Sturge-Weber Gene Discovery: An Agenda for Future Research
  161. Sturge-Weber Syndrome: Brain Magnetic Resonance Imaging and Neuropathology Findings
  162. Editorial: Essential Pathways and Circuits of Autism Pathogenesis
  163. Advances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations from the 2015 Strategic Planning Conference
  164. Cell-type-specific miR-431 dysregulation in a motor neuron model of spinal muscular atrophy
  165. Epileptogenesis in neurocutaneous disorders with focus in Sturge Weber syndrome
  166. Engineering microdeletions and microduplications by targeting segmental duplications with CRISPR
  167. Clinical Electroencephalographic Biomarker for Impending Epilepsy in Asymptomatic Tuberous Sclerosis Complex Infants
  168. Neurological Comorbidities in Autism Spectrum Disorder
  169. Essential Pathways and Circuits of Autism Pathogenesis
  170. Congenital disorders of autophagy: an emerging novel class of inborn errors of neuro-metabolism
  171. Disorders of Microtubule Function in Neurons: Imaging Correlates
  172. Super-resolution reconstruction in frequency, image, and wavelet domains to reduce through-plane partial voluming in MRI
  173. Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing
  174. Adopting Rare Diseases
  175. Genes, circuits, and precision therapies for autism and related neurodevelopmental disorders
  176. Tubers are neither static nor discrete
  177. Characterizing brain tissue by assessment of the distribution of anisotropic microstructural environments in diffusion-compartment imaging (DIAMOND)
  178. TSC2 controls neuronal development through FOXO1 and mitochondrial function in Autism Spectrum Disorders patient derived human neurons
  179. Cerebellar Development and Autism Spectrum Disorder in Tuberous Sclerosis Complex
  180. Pediatric Neurology 2014 Trainee Publication Award Winner: Dr. Mitchel T. Williams
  181. The Stress-Induced Atf3-Gelsolin Cascade Underlies Dendritic Spine Deficits in Neuronal Models of Tuberous Sclerosis Complex
  182. Developing therapies for spinal muscular atrophy
  183. Cerebellar associative sensory learning defects in five mouse autism models
  184. Therapeutic Advances in Autism and Other Neurodevelopmental Disorders
  185. Tuberous Sclerosis Complex
  186. Longitudinal Changes in Diffusion Properties in White Matter Pathways of Children With Tuberous Sclerosis Complex
  187. Visual Evoked Potentials as a Readout of Cortical Function in Infants With Tuberous Sclerosis Complex
  188. Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism
  189. The Circadian Protein BMAL1 Regulates Translation in Response to S6K1-Mediated Phosphorylation
  190. Autism and the synapse
  191. Vigabatrin can enhance electroretinographic responses in pigmented and albino rats
  192. Altered Structural Brain Networks in Tuberous Sclerosis Complex
  193. Tuberous Sclerosis Associated Neuropsychiatric Disorders (TAND) and the TAND Checklist
  194. Genetics of neurocutaneous disorders
  195. A Vascular Model of Tsc1 Deficiency Accelerates Renal Tumor Formation with Accompanying Hemangiosarcomas
  196. Gene Therapy for Childhood Neurological Disease
  197. The Neurology of mTOR
  198. Parkinson's disease: A disorder of axonal mitophagy?
  199. Somatic Mutations in Cerebral Cortical Malformations
  200. SMN regulates axonal local translation via miR-183/mTOR pathway
  201. Early developmental trajectories associated with ASD in infants with tuberous sclerosis complex
  202. Copy number variation plays an important role in clinical epilepsy
  203. RASA1 functions in EPHB4 signaling pathway to suppress endothelial mTORC1 activity
  204. Mechanism-Based Treatment in Tuberous Sclerosis Complex
  205. Trust but Verify: The Introduction of Plagiarism Detection Software
  206. EphA7 signaling guides cortical dendritic development and spine maturation
  207. Neuronal Tsc1/2 complex controls autophagy through AMPK-dependent regulation of ULK1
  208. A Mathematical Framework for the Registration and Analysis of Multi-Fascicle Models for Population Studies of the Brain Microstructure
  209. Autism Spectrum Disorders in Tuberous Sclerosis
  210. Divergent dysregulation of gene expression in murine models of fragile X syndrome and tuberous sclerosis
  211. Both Maternal and Pup Genotype Influence Ultrasonic Vocalizations and Early Developmental Milestones inTsc2+/−Mice
  212. Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
  213. Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
  214. Diffusion tensor imaging and related techniques in tuberous sclerosis complex: review and future directions
  215. A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS
  216. The Neuroprotective Drug Riluzole Acts via Small Conductance Ca2+-Activated K+ Channels to Ameliorate Defects in Spinal Muscular Atrophy Models
  217. SMA-MAP: A Plasma Protein Panel for Spinal Muscular Atrophy
  218. Pediatric Neurocritical Care: A Neurology Consultation Model and Implication for Education and Training
  219. Brain functional networks in syndromic and non-syndromic autism: a graph theoretical study of EEG connectivity
  220. A Magnetic Resonance Imaging Study of Cerebellar Volume in Tuberous Sclerosis Complex
  221. Fragile X Syndrome Therapeutics: Translation, Meet Translational Medicine
  222. Characterizing the DIstribution of Anisotropic MicrO-structural eNvironments with Diffusion-Weighted Imaging (DIAMOND)
  223. Prenatal Rapamycin Results in Early and Late Behavioral Abnormalities in Wildtype C57Bl/6 Mice
  224. Atypical Face Processing in Children With Tuberous Sclerosis Complex
  225. Targeted treatment trials for tuberous sclerosis and autism: no longer a dream
  226. Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice
  227. Graded loss of tuberin in an allelic series of brain models of TSC correlates with survival, and biochemical, histological and behavioral features
  228. Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy
  229. Impaired Language Pathways in Tuberous Sclerosis Complex Patients with Autism Spectrum Disorders
  230. Endothelial cell-fatty acid binding protein 4 promotes angiogenesis: role of stem cell factor/c-kit pathway
  231. Candidate Proteins, Metabolites and Transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study
  232. Evaluation of SMN Protein, Transcript, and Copy Number in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study
  233. Correction for Alexander et al., ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS
  234. Erratum: Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice
  235. Micro-duplications of 1q32.1 associated with neurodevelopmental delay
  236. Loss of White Matter Microstructural Integrity Is Associated with Adverse Neurological Outcome in Tuberous Sclerosis Complex
  237. Translational research
  238. Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex
  239. Febrile infection-related epilepsy syndrome (FIRES): Does duration of anesthesia affect outcome?
  240. A Genetic Model to Dissect the Role of Tsc-mTORC1 in Neuronal Cultures
  241. NMDA Mediated Contextual Conditioning Changes miRNA Expression
  242. Pediatric epileptology
  243. Febrile infection-related epilepsy syndrome (FIRES): Pathogenesis, treatment, and outcome
  244. Mechanisms of neurocognitive dysfunction and therapeutic considerations in tuberous sclerosis complex
  245. TSC1/TSC2 signaling in the CNS
  246. SMN Deficiency Reduces Cellular Ability to Form Stress Granules, Sensitizing Cells to Stress
  247. Neurocutaneous Syndromes
  248. MicroRNA Profiling Reveals Two Distinct p53-Related Human Pluripotent Stem Cell States
  249. Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice
  250. EphB-Mediated Degradation of the RhoA GEF Ephexin5 Relieves a Developmental Brake on Excitatory Synapse Formation
  251. The syndrome of perisylvian polymicrogyria with congenital arthrogryposis
  252. Eph receptor and mTOR pathway crosstalk: Implications for cancer
  253. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS
  254. Diffusion Features of White Matter in Tuberous Sclerosis With Tractography
  255. Tsc2-Rheb signaling regulates EphA-mediated axon guidance
  256. Maximum A Posteriori Estimation of Isotropic High-Resolution Volumetric MRI from Orthogonal Thick-Slice Scans
  257. Murine Glut-1 transporter haploinsufficiency: Postnatal deceleration of brain weight and reactive astrocytosis
  258. Tuberous Sclerosis Complex Activity Is Required to Control Neuronal Stress Responses in an mTOR-Dependent Manner
  259. Cardiac Rhabdomyomas in Tuberous Sclerosis Complex Show Apoptosis Regulation and mTOR Pathway Abnormalities
  260. Cardiac rhabdomyoma in tuberous sclerosis: Hyperactive Erk signaling
  261. Promoting Axon Regeneration in the Adult CNS by Modulation of the PTEN/mTOR Pathway
  262. Tuberous sclerosis complex proteins control axon formation
  263. Human CHN1 Mutations Hyperactivate  2-Chimaerin and Cause Duane's Retraction Syndrome
  264. Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function
  265. Loss of the Tuberous Sclerosis Complex Tumor Suppressors Triggers the Unfolded Protein Response to Regulate Insulin Signaling and Apoptosis
  266. Characterization of Autism in Young Children With Tuberous Sclerosis Complex
  267. Clinical Presentation and Diagnosis of Tuberous Sclerosis Complex in Infancy
  268. A Mouse Model of Tuberous Sclerosis: Neuronal Loss of Tsc1 Causes Dysplastic and Ectopic Neurons, Reduced Myelination, Seizure Activity, and Limited Survival
  269. Tuberous Sclerosis Complex and Epilepsy: Recent Developments and Future Challenges
  270. Neonatal Subependymal Giant Cell Astrocytoma: New Case and Review of Literature
  271. Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism
  272. S6K1 Regulates GSK3 under Conditions of mTOR-Dependent Feedback Inhibition of Akt
  273. Cardiac rhabdomyomas in tuberous sclerosis complex show apoptosis regulation and mTOR pathway abnormalities
  274. Deletion of chromosome 1p36 is associated with periventricular nodular heterotopia
  275. Regulation of EphA4 Kinase Activity Is Required for a Subset of Axon Guidance Decisions Suggesting a Key Role for Receptor Clustering in Eph Function
  276. Eph-Dependent Tyrosine Phosphorylation of Ephexin1 Modulates Growth Cone Collapse
  277. Vav Family GEFs Link Activated Ephs to Endocytosis and Axon Guidance
  278. Focal seizure and cerebral contrast retention after cardiac catheterization
  279. Prolonged treatment for acute symptomatic refractory status epilepticus
  280. Outcome of Severe Refractory Status Epilepticus in Children
  281. EphA Receptors Regulate Growth Cone Dynamics through the Novel Guanine Nucleotide Exchange Factor Ephexin
  282. Prolonged Treatment of Refractory Status Epilepticus in a Child
  283. Prolonged Treatment of Refractory Status Epilepticus in a Child
  284. Antiepileptic drug-induced visual hallucinations in a child
  285. Hydrocephalus associated with glycogen storage disease type II (pompe’s disease)
  286. Expression of PTPH1, a rat protein tyrosine phosphatase, is restricted to the derivatives of a specific diencephalic segment.
  287. Seven protein tyrosine phosphatases are differentially expressed in the developing rat brain
  288. Location of nicotinic and muscarinic cholinergic and μ-opiate receptors in rat cerebral neocortex: evidence from thalamic and cortical lesions
  289. Molecular identification of the lugaro cell in the cat cerebellar cortex